Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2111094 | Cancer Genetics and Cytogenetics | 2009 | 4 Pages |
Abstract
We report a rare cryptic ins(12;9)(p13;q34q34), a chromosomal abnormality involving the ABL1 (9q34) and the ETV6 (alias TEL; 12p13) genes, detectable only by fluorescence in situ hybridization (FISH), in a patient with Philadelphia-negative chronic myeloid leukemia (CML). Using reverse 4′,6-diamidino-2-phenylindole banding on metaphase cells, FISH analysis with BCR/ABL dual-fusion and ETV6 break-apart probes showed that a third ABL signal was inserted into 12p, splitting the ETV6 signal into two adjacent signals. CML patients with an ABL1/ETV6 fusion historically have demonstrated a variable and sometimes transient response to treatment with imatinib mesylate, which was also the case in the present patient.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
JoAnn C. Kelly, Nasrin Shahbazi, Jay Scheerle, Jennifer Jahn, Stephany Suchen, Nicole C. Christacos, Philip N. Mowrey, Mary H. Witt, Alden Hostetter, Aurelia M. Meloni-Ehrig,